Suppr超能文献

二尖瓣环钙化患者的开放性心房经导管二尖瓣置换术。

Open atrial transcatheter mitral valve replacement in patients with mitral annular calcification.

作者信息

Russell Hyde M, Guerrero Mayra E, Salinger Michael H, Manzuk Melissa A, Pursnani Amit K, Wang Dee, Nemeh Hassan, Sakhuja Rahul, Melnitchouk Serguei, Pershad Ashish, Fang H Kenith, Said Sameh M, Kauten James, Tang Gilbert H L, Aldea Gabriel, Feldman Ted E, Bapat Vinnie N, George Isaac M

机构信息

Division of Cardiovascular Surgery, NorthShore University HealthSystem, Evanston, Ill.

Department of Cardiovascular Medicine, Mayo Clinic Hospital, Rochester, Minn.

出版信息

J Thorac Cardiovasc Surg. 2019 Mar;157(3):907-916. doi: 10.1016/j.jtcvs.2018.09.003. Epub 2018 Sep 20.

Abstract

BACKGROUND

Mitral valve replacement in the setting of severe mitral annular calcification remains a surgical challenge. Transcatheter mitral valve replacement (TMVR) using an aortic balloon-expandable transcatheter heart valve is emerging as a potential treatment option for high surgical risk patients. Transseptal, transapical, or transatrial access is not always feasible, so an understanding of alternative implantation techniques is important.

OBJECTIVES

The authors sought to present a step-by-step description of a contemporary transatrial TMVR technique using balloon-expandable aortic transcatheter heart valves. This procedure has evolved over time to address valve migration, left ventricular outflow tract obstruction, and paravalvular leak. The authors present a refined technique that has been associated with the most reproducible outcomes.

METHODS

A step-by-step description of the TMVR technique and outcomes of 8 patients treated using this technique are described. Baseline patient clinical and echocardiographic characteristics and 30-day post-TMVR outcomes are presented.

RESULTS

Eight patients underwent transatrial TMVR at a single institution. Five had previous cardiac surgery. Mean STS score was 8%. Technical success by MVARC (Mitral Valve Academic Research Consortium) criteria was 100%. There was zero in-hospital and 30-day mortality. Procedural success by MVARC criteria at 30 days was 100%. Paravalvular leak immediately post-implant was none or trace in 6 and mild in 1.

CONCLUSIONS

The technique described is reproducible and was associated with favorable outcomes in this early experience. It represents a useful technique for the treatment of mitral valve disease in the setting of severe annular calcification. A structured and defined implantation technique is critical to investigators as this field evolves.

摘要

背景

在严重二尖瓣环钙化的情况下进行二尖瓣置换术仍然是一项外科挑战。使用主动脉球囊扩张式经导管心脏瓣膜进行经导管二尖瓣置换术(TMVR)正在成为高手术风险患者的一种潜在治疗选择。经房间隔、经心尖或经心房入路并不总是可行的,因此了解替代植入技术很重要。

目的

作者试图逐步描述一种使用球囊扩张式主动脉经导管心脏瓣膜的当代经心房TMVR技术。随着时间的推移,该手术不断发展以解决瓣膜移位、左心室流出道梗阻和瓣周漏问题。作者介绍了一种与之相关的、具有最高可重复性结果的改良技术。

方法

描述了TMVR技术的逐步过程以及使用该技术治疗的8例患者的结果。列出了患者的基线临床和超声心动图特征以及TMVR术后30天的结果。

结果

8例患者在单一机构接受了经心房TMVR。5例患者曾接受过心脏手术。平均胸外科医师协会(STS)评分8%。根据二尖瓣学术研究联盟(MVARC)标准,技术成功率为100%。住院期间及30天死亡率为零。根据MVARC标准,30天时的手术成功率为100%。植入后即刻瓣周漏无或微量的有6例,轻度的有1例。

结论

所描述的技术具有可重复性,在这一早期经验中取得了良好的结果。它代表了一种在严重瓣环钙化情况下治疗二尖瓣疾病的有用技术。随着该领域的发展,一种结构化且明确的植入技术对研究人员至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验